Cleared Special

K232162 - Autotome Pro RX 39 Sphincterotome

Also marketed or referenced as:
Autotome Pro RX 44 Sphincterotome Jagtome Pro RX 44 Sphincterotome Jagtome Pro RX 39 Sphincterotome Dreamtome Pro RX 44 Sphincterotome Hydratome Pro RX 44 Sphincterotome Jagtome Revolution Pro RX 39 Sphincterotome

K232162 is the FDA 510(k) clearance for Autotome Pro RX 39 Sphincterotome by Boston Scientific Corporation. It is a Class 2 Gastroenterology & Urology device (product code KNS) cleared through the Special 510(k) pathway after a 24-day FDA review.

K232162 · Boston Scientific Corporation · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2023
Decision
24d
Days
Class 2
Risk

K232162 is an FDA 510(k) clearance for the Autotome Pro RX 39 Sphincterotome. Classified as Unit, Electrosurgical, Endoscopic (with Or Without Accessories) (product code KNS), Class II - Special Controls.

Submitted by Boston Scientific Corporation (Marlboro, US). The FDA issued a Cleared decision on August 14, 2023 after a review of 24 days - a notably fast clearance cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.4300 - the FDA gastroenterology and urology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Boston Scientific Corporation devices

Submission Details

510(k) Number K232162 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 21, 2023
Decision Date August 14, 2023
Days to Decision 24 days
Submission Type Special
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
106d faster than avg
Panel avg: 130d · This submission: 24d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code KNS Unit, Electrosurgical, Endoscopic (with Or Without Accessories)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.4300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - KNS Unit, Electrosurgical, Endoscopic (with Or Without Accessories)

All 114
Devices cleared under the same product code (KNS) and FDA review panel - the closest regulatory comparables to K232162.
Speedboat Flush SB1 Instrument
K230328 · Creo Medical, Ltd. · Oct 2023
AXIOS Stent and Electrocautery-Enhanced Delivery System (6mmx8mm)
K233318 · Boston Scientific Corporation · Oct 2023
ELRA Electrode (7-2B11S, 7-2B11L, 7-2B22S, 7-2B22L, 7-4B18S, 7-4B18L, 7-4B33S, 7-4B33L)
K233113 · Starmed Co., Ltd. · Oct 2023
Habib EndoHPB
K231533 · Boston Scientific Corporation · Jun 2023
Sphincterotome
K222421 · Hangzhou AGS MedTech Co., Ltd. · May 2023
Optimos™ Cystotome
K223256 · Taewoong Medical Co., Ltd. · Apr 2023